Breaking into established mature markets is a slow process. We should continue to pursue them but in the
meanwhile we should concentrate on China. From what I hear the Chinese surgeons are anxious to
use our patch since their patches are not world class. I doubt that they are using Uncle Sams material
so this is a golden opportunity for Admedus to take a lead in this massive market which might be easier to
crack as opposed to EU and the USA with all their hurdles. Get a Chinese partner and do a deal.
The number of annual patches for China could be in excess of 100,000
Welcome to the fourth quarter, page-50
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.035(0.19%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $17.65 | $75.19K | 4.184K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 414 | $17.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |